Pushing the Frontiers of Knowledge: The 2017 Killam Prize

“We were able to prove that treatment could actually lead to an AIDS-free generation — not just free of AIDS, but free of HIV transmission.” – Dr. Julio Montaner

Dr. Julio Montaner (Health Sciences) – Dr. Julio Montaner is the Director of the British Columbia Centre for Excellence in HIV/AIDS. Originally from Argentina, he immigrated to Canada more than 30 years ago and his innovations in HIV/AIDS treatment helped save millions of lives. He is a strong advocate of ‘treatment as prevention’ as well as safe injection sites and needle exchange programs.

Once a year the Canada Council Killam Prize is bestowed on five of Canada’s top academics in five different fields. Paul Kennedy interviews this year’s winners and finds out what inspires them to break new ground. Passion, drive and creativity fuel Canada’s intellectual heavyweights, no matter the field.

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below

Laboratory Order Forms

Start typing and press enter to search